Ciliatech Raises €3.5M in Series A Funding
Ciliatech notes the funds will advance the development of their disruptive glaucoma implant CID and initiate clinical trials in Europe, paving the way for CE mark approval.
April 25, 2023
A Digital Publication for the Practicing Medical Specialist, Industry Executive, & Investor
Ciliatech notes the funds will advance the development of their disruptive glaucoma implant CID and initiate clinical trials in Europe, paving the way for CE mark approval.